1 active not recruiting, 1 not yet recruiting, 1 recruiting, 1 withdrawn. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Active not recruiting 1, Not yet recruiting 1 |
Follow targeted therapy: new trials by email Literature Review of targeted therapy trials Research Report on targeted therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma FOLFOX regimen, Immunotherapy, targeted therapy - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | BinYong Liang | 100 | 2026-04-30 | 2026-04-13 |
| A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects Fecal microbiota transplantation (FMT) - Fecal Microbiota Transplantation (FMT), Gastrointestinal Neoplasms | Phase 1 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 90 | 2025-09-01 | 2026-01-06 |
| A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma Tislelizumab, Afatinib, Lysogenic HSV virus. - HNSCC, Lysogenic HSV Virus | Phase 1 / Phase 2 | Active not recruiting | West China Hospital | 29 | 2025-06-10 | 2026-07-01 |
| A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus Lysogenic HSV virus., Tislelizumab, Afatinib - HNSCC, Lysogenic HSV Virus | Phase 1 | Withdrawn | West China Hospital | 2024-12-15 | 2026-10-16 |
Squamous Cell Carcinoma of Head and Neck (2) · Carcinoma, Hepatocellular (1) · Drug-Related Side Effects and Adverse Reactions (1) · Gastrointestinal Neoplasms (1)
West China Hospital (2) · BinYong Liang (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1)
China (3)
Xingchen Peng (2)